Context

BlueBee is a Netherlands-based SaaS provider of cloud-based genomics data analysis solutions.

BlueBee serves pharmaceutical companies, assay providers and instrument manufacturers as well as government-funded research initiatives, in Europe and the US.

In order to accelerate BlueBee’s platform adoption, the Company contemplated either a sizeable fundraising or a synergetic M&A deal.

US-based DNA sequencing world-leader Illumina recognized the value of BlueBee’s technology and decided to integrate it to its own solution through the acquisition of the Company.

About BlueBee

BlueBee is a global bioinformatics software solutions provider offering fit-for-purpose configurability on its BlueBee Genomics Platform. BlueBee data analysis solutions serve to analyze, interpret, report, and learn from aggregated data, for research and diagnostic assay manufacturers, high-throughput service providers, large project initiatives, and biopharma.

Discover BlueBee

Olivier Garnier

Investment Banking

Vincent Meunier

Investment Banking

Romain Ellul

Investment Banking

Mickael Dubourd

Investment Banking

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center